ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001511900

Broadfin Healthcare Master Fund Ltd

CIK 0001511900 Name as filed on the most recent filing

Filed as Broadfin Healthcare Master Fund Ltd (33)

125 transaction lines · from 33 filings · filed 2014-07-23 to 2021-11-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2017-11-30 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 11,472 disposed 5.97 68,487.84 Form 4, filing 0000919574-17-008470
2017-11-30 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 100 disposed 6.03 603.00 Form 4, filing 0000919574-17-008470
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 100,000 disposed 9.55 955,000.00 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 50,000 disposed 9.55 477,500.00 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 6,381 disposed 9.71 61,959.51 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 6,322 disposed 9.63 60,880.86 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 5,000 disposed 9.62 48,100.00 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 500 disposed 9.69 4,845.00 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 100 disposed 9.71 971.00 Form 4, filing 0000919574-17-008445
2017-11-30 Recro Pharma, Inc.
REPH 		S, Open-market sale 100 disposed 9.61 961.00 Form 4, filing 0000919574-17-008445
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 50,000 disposed 6.50 325,000.00 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 49,865 disposed 6.60 329,109.00 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 7,700 disposed 6.35 48,895.00 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 5,751 disposed 6.55 37,669.05 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 1,900 disposed 6.26 11,894.00 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 1,000 disposed 6.66 6,660.00 Form 4, filing 0000919574-17-008470
2017-11-29 Aratana Therapeutics, Inc.
PETX 		S, Open-market sale 300 disposed 6.28 1,884.00 Form 4, filing 0000919574-17-008470
2017-11-29 Recro Pharma, Inc.
REPH 		S, Open-market sale 3,764 disposed 9.66 36,360.24 Form 4, filing 0000919574-17-008445
2017-11-29 Recro Pharma, Inc.
REPH 		S, Open-market sale 2,200 disposed 9.68 21,296.00 Form 4, filing 0000919574-17-008445
2017-11-29 Recro Pharma, Inc.
REPH 		S, Open-market sale 700 disposed 9.68 6,776.00 Form 4, filing 0000919574-17-008445
2017-11-28 Recro Pharma, Inc.
REPH 		S, Open-market sale 24,430 disposed 9.71 237,215.30 Form 4, filing 0000919574-17-008445
2017-11-28 Recro Pharma, Inc.
REPH 		S, Open-market sale 21,619 disposed 9.56 206,677.64 Form 4, filing 0000919574-17-008445
2017-11-28 Recro Pharma, Inc.
REPH 		S, Open-market sale 1,500 disposed 9.68 14,520.00 Form 4, filing 0000919574-17-008445
2017-11-24 Recro Pharma, Inc.
REPH 		S, Open-market sale 5,900 disposed 9.37 55,283.00 Form 4, filing 0000919574-17-008352
2017-11-24 Recro Pharma, Inc.
REPH 		S, Open-market sale 5,800 disposed 9.39 54,462.00 Form 4, filing 0000919574-17-008352
2017-11-24 Recro Pharma, Inc.
REPH 		S, Open-market sale 2,913 disposed 9.32 27,149.16 Form 4, filing 0000919574-17-008352
2017-11-24 Recro Pharma, Inc.
REPH 		S, Open-market sale 2,051 disposed 9.31 19,094.81 Form 4, filing 0000919574-17-008352
2017-11-24 Recro Pharma, Inc.
REPH 		S, Open-market sale 1,450 disposed 9.48 13,746.00 Form 4, filing 0000919574-17-008352
2017-11-22 Recro Pharma, Inc.
REPH 		S, Open-market sale 48,566 disposed 9.37 455,063.42 Form 4, filing 0000919574-17-008352
2017-11-22 Recro Pharma, Inc.
REPH 		S, Open-market sale 3,088 disposed 9.36 28,903.68 Form 4, filing 0000919574-17-008352
2017-11-21 Recro Pharma, Inc.
REPH 		S, Open-market sale 100,000 disposed 9.50 950,000.00 Form 4, filing 0000919574-17-008352
2017-11-21 Recro Pharma, Inc.
REPH 		S, Open-market sale 2,440 disposed 9.37 22,862.80 Form 4, filing 0000919574-17-008352
2017-11-17 Corium International, Inc.
CORI 		S, Open-market sale 100,000 disposed 10.95 1,095,000.00 Form 4, filing 0000919574-17-008261
2017-11-17 Corium International, Inc.
CORI 		S, Open-market sale 65,345 disposed 11.01 719,448.45 Form 4, filing 0000919574-17-008261
2017-11-17 Corium International, Inc.
CORI 		S, Open-market sale 25,000 disposed 10.95 273,750.00 Form 4, filing 0000919574-17-008261
2017-11-17 Corium International, Inc.
CORI 		S, Open-market sale 9,255 disposed 10.96 101,434.80 Form 4, filing 0000919574-17-008261
2017-11-16 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 60,000 disposed 18.05 1,083,000.00 Form 4, filing 0000919574-17-008286
2017-11-16 Corium International, Inc.
CORI 		S, Open-market sale 250,000 disposed 10.97 2,742,500.00 Form 4, filing 0000919574-17-008261
2017-11-16 Corium International, Inc.
CORI 		S, Open-market sale 25,000 disposed 10.88 272,000.00 Form 4, filing 0000919574-17-008261
2017-11-16 Corium International, Inc.
CORI 		S, Open-market sale 25,000 disposed 10.85 271,250.00 Form 4, filing 0000919574-17-008261
2017-11-16 Corium International, Inc.
CORI 		S, Open-market sale 400 disposed 10.97 4,388.00 Form 4, filing 0000919574-17-008261
2017-11-02 Corium International, Inc.
CORI 		S, Open-market sale 150,000 disposed 11.05 1,657,500.00 Form 4, filing 0000919574-17-007554
2017-10-04 Corium International, Inc.
CORI 		S, Open-market sale 218,100 disposed 11.01 2,401,106.52 Form 4, filing 0000919574-17-007169
2017-06-23 Avadel Pharmaceuticals PLC
AVDL 		S, Open-market sale 161,000 disposed 10.60 1,706,600.00 Form 4, filing 0000919574-17-005013
2017-06-22 Avadel Pharmaceuticals PLC
AVDL 		S, Open-market sale 100,000 disposed 10.80 1,080,000.00 Form 4, filing 0000919574-17-005013
2017-02-15 Progenics Pharmaceuticals Inc
PGNX 		S, Open-market sale 150,000 disposed 9.55 1,432,500.00 Form 4, filing 0000919574-17-002069
2017-02-14 Progenics Pharmaceuticals Inc
PGNX 		S, Open-market sale 150,000 disposed 9.68 1,452,000.00 Form 4, filing 0000919574-17-002069
2017-02-14 Progenics Pharmaceuticals Inc
PGNX 		S, Open-market sale 100,000 disposed 9.70 970,000.00 Form 4, filing 0000919574-17-002069
2017-02-14 Progenics Pharmaceuticals Inc
PGNX 		S, Open-market sale 52,600 disposed 9.70 510,220.00 Form 4, filing 0000919574-17-002069
2017-02-14 Progenics Pharmaceuticals Inc
PGNX 		S, Open-market sale 50,000 disposed 9.70 485,000.00 Form 4, filing 0000919574-17-002069

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Broadfin Healthcare Master Fund Ltd, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001511900

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.